VF released their earnings today and raised outlook for the full year. Since the previous quarter VF has announced the sale of the Reef® brand to The Rockport Group on October 4th. And on August 13th VF announced the intention to create two independent publicly traded companies; one apparel and footwear and the other jeans …
Continue reading “VF raises dividend and full year outlook, but growth is slowing down”
J&J released their Q3 results today: – 2018 Third-Quarter Sales of $20.3 Billion Increased 3.6% versus 2017 – 2018 Third-Quarter EPS was $1.44 – 2018 Adjusted Third-Quarter EPS of $2.05 increased 7.9%* – Strong Operational Sales and Adjusted EPS Growth* – Company Increased Sales and EPS Guidance The Q3 results spawned the following headlines. – …
Continue reading “Johnson & Johnson Reports 2018 Third-Quarter Results”
Today Ely Lilly (LLY) announced the positive results on a phase 2 diabetes drug of theirs (LY3298176) via a publication in The Lancet, a presentation at the annual meeting of the European Association for the Study of Diabetes (EASD) and the press release below: Lilly’s Investigational Dual GIP and GLP-1 Receptor Agonist Shows Significant Reduction …
Continue reading “Eli Lilly and phase results 2 on their dual GIP/GLP1 receptor agonist LY3298176”